News

Researchers suppresses side effects of mRNA therapeutics, broadly applicable platform for safer, personalised treatments​

FDA approves epcoritamab-bysp for follicular lymphoma indications

FDA approves selumetinib for adults with neurofibromatosis type 1 with symptomatic, inoperable plexiform neurofibromas

FDA grants traditional approval to tarlatamab-dlle for extensive stage small cell lung cancer

A revolution in cancer rehabilitation powered by robotic exoskeletons

Small team, big impact: Automation helps relieve symptoms to keep cancer patients out of the ER

An overlooked hormone eyed as deadly driver of postmenopausal breast cancer in women with obesity

AI-driven study reports identifying (Z)-endoxifen as a potential therapeutic candidate for glioblastoma

Light-sensitive microbial protein may herald new cancer therapies

Researchers lead major treatment overhauls for acute myeloid leukaemia

Researchers finds potential new treatment for aggressive ovarian cancer

Scientists can finally answer an old question about cellular ageing